Financial headroom per patient undergoing pancreatoduodenectomy for novel prophylactic treatment strategies of delayed gastric emptying
This model shows the budget neutral financial headroom per patient undergoing pancreatoduodenectomy for novel prophylactic treatment strategies of delayed gastric emptying. The budget neutral financial headroom per patient is calculated by following risk reductions (due to new prophylactic treatment) relative to the baseline risk of delayed gastric emptying.
Research authors: Michiel F.G. Francken, Stijn van Roessel, Rutger-Jan Swijnenburg, Joris I. Erdmann, Olivier R. Busch, Marcel G.W. Dijkgraaf, Marc G. Besselink
Details Formula Study characteristics Files & References
Model author
Model ID
2272
Version
1.25
Revision date
2020-07-10
Specialty
MeSH terms
  • Gastroparesis
  • Pancreatoduodenectomy
  • Cost
  • Surgery
  • Model type
    Custom model (Calculation)
    Status
    public
    Rating
    No rating criteria met
    Share
    Formula

    Additional information

    Introduction: Delayed gastric emptying (DGE) following pancreatoduodenectomy (PD) has unknown costs and prophylactic treatment is lacking. This study aims to estimate the hospital costs of DGE and forecast the financial implications per patient for novel prophylactic treatment, while containing costs.
     
    Materials and methods: Retrospective analysis of a prospective database including patients after PD in a single center (2010–2017). Only ISGPS grade B/C defined DGE was included. In-hospital costs for DGE were calculated by comparing patient groups with and without other complications and with and without DGE. The financial headroom per patient was calculated for the extent of DGE risk reduction (0-100%) for distinct baseline risk scenarios (15-30%).
     
    Results: Overall, 581 patients after PD were included with 26.9% grade B/C DGE. Patients with isolated DGE (n=90) had €10,295 higher in-hospital costs than patients without complications (n=333). Patients with other complications including DGE (n=66) had €9,008 higher in-hospital costs than patients with other complications without DGE (n=92). The developed model showed that, based on the current cohort, the financial headroom for a novel prophylactic treatment per patient undergoing PD was €975 per absolute decrease of DGE risk in all patients undergoing PD of 10%.
     
    Discussion: In the studied healthcare situation, the occurrence of DGE adds €9,000-10.000 to the in-hospital costs of PD, both in patients with and without other complications. The developed model, readily available via www.pancreascalculator.com, gives insight into the financial headroom for novel prophylactic treatments in all patients undergoing PD aimed to reduce DGE.

    Study Population

    Total population size: 581
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Additional characteristics

    No additional characteristics defined
    Financial headroom per patient undergoing pancreatoduodenectomy for novel prophylactic treatment strategies of delayed gastric emptying
    V-1.25-2272.20.07.10
    Refer to Intended Use for instructions before use
    Evidencio B.V., Irenesingel 19, 7481 GJ, Haaksbergen, the Netherlands

    Related files

    No related files available

    Supporting Publications

    No supporting publications available

    Budget neutral financial headroom per patient for novel prophylactic treatment strategies of delayed gastric emptying:
    ...
    € (March, 2020)

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Result
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Budget neutral financial headroom per patient for novel prophylactic treatment strategies of delayed gastric emptying: € (March, 2020)

    {{ resultSubheader }}
    {{ table.title }}
    {{ row }}
    {{ chart.title }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.